Log in
Enquire now
Stalicla

Stalicla

Stalicla is a drug development platform for neurodevelopmental disorders founded in 2017 by Lynn Durham.

OverviewStructured DataIssuesContributors

Contents

stalicla.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
Healthcare
Healthcare
Medicine
Medicine
‌
Neurobiology
Medical diagnostics
Medical diagnostics
Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder (ASD)
...
Location
Geneva
Geneva
Switzerland
Switzerland
B2X
B2B
B2B
CEO
‌
Lynn Durham
Founder
‌
Lynn Durham
Number of Employees (Ranges)
11 – 50
Email Address
info@stalicla.com
Investors
Addex Therapeutics
Addex Therapeutics
Founded Date
2017
Total Funding Amount (USD)
27,471,700
Latest Funding Round Date
June 30, 2025
CTO
CFO
‌
Laurent Forestier
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
Switzerland
Switzerland
Headquarters
Geneva
Geneva

Other attributes

Latest Funding Round Amount (USD)
2,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Stalicla

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.